Improved HED delivery into breast tumors and enhanced its anti‐tumor efficacy by promoting mitochondria‐mediated cell apoptosis and autophagy via upregulation of Beclin‐1 and LC3‐II. This evidence concerns the gene BECN1 and breast neoplasm.